Diagnosis and treatment of local forms of alopecia areata in children
- 1 July 2025
- journal article
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 24 (3)
Abstract
Alopecia areata (AA) is a genetically caused chronic autoimmune disease, which is characterized by nonscarring temporary or persistent hair loss. The prevalence of this disease has increased in recent decades, and currently up to 3.83% of patients in dermatological facilities seek care with the problem of focal hair loss. The incidence of AA in children increases with age. Thus, the highest prevalence is recorded among adolescents aged 12—17 years. It has also been observed that concomitant autoimmune diseases are 2.59 times more often found in children with AA than in children without AA. Focal hair loss affects everyday life, always significantly reducing the quality of life. AA multifactorial pathogenesis, recurrent course as well as visible cosmetic defect necessitate a comprehensive approach in the diagnosis and treatment of this condition, as well as the most effective modern treatment methods application. The article discusses epidemiology, etiology, development mechanisms, clinical features of AA, describes the main methods of diagnosis and control of performed therapy, particularly trichoscopic signs, presents the most commonly used scales for determining the process severity as well as modern methods of managing patients with localized form of the disease, practical application of which is demonstrated in a clinical case.Keywords
This publication has 34 references indexed in Scilit:
- Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured PopulationJAMA Dermatology, 2023
- Prevalence and Odds of Depressive and Anxiety Disorders and Symptoms in Children and Adults With Alopecia AreataJAMA Dermatology, 2023
- Incidence and comorbidities of pediatric alopecia areata: A retrospective matched cohort study using the Rochester Epidemiology ProjectJournal of the American Academy of Dermatology, 2022
- Development of the alopecia areata scale for clinical use: Results of an academic–industry collaborative effortJournal of the American Academy of Dermatology, 2022
- Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysisJournal of the American Academy of Dermatology, 2020
- Objective outcome measures: Collecting meaningful data on alopecia areataJournal of the American Academy of Dermatology, 2018
- Clobetasol Propionate, 0.05%, vs Hydrocortisone, 1%, for Alopecia Areata in ChildrenJAMA Dermatology, 2014
- Hair and scalp dermatoscopyJournal of the American Academy of Dermatology, 2012
- Alopecia areata investigational assessment guidelines–Part IIJournal of the American Academy of Dermatology, 2004
- Randomized Double-blind Placebo-Controlled Trial in the Treatment of Alopecia Areata With 0.25% Desoximetasone CreamArchives of Dermatology, 2000